Research Must Go On
This is the final installment of my Memo series illustrating why research funding for basic and clinical trials should never stop unless the approach is obviously misdirected. Delaying research due to the dogma of the day is bad; delaying it because someone believes in a refuted dogma is worse. This is not a debate on […]